Primary Care centre
Welcome,         Profile    Billing    Logout  
 1 Trial 
3 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
López, Marcelino Bermúdez
ILERVAS, NCT03228459: The Project: Assessing the Prevalence of Subclinical Vascular Disease and Hidden Kidney Disease

Active, not recruiting
N/A
16660
Europe
Dried blood spot test, Urine test, Artery ultrasound, Ankle-brachial index, Spirometry, Determination of advanced glycation-end products, Atrial fibrillation screening, Biological sample collection, Result and recommendation report, Pulse wave velocity
Institut de Recerca Biomèdica de Lleida, Diputació de Lleida, Jaume Arnó Renal Foundation, Unit of Detection and Treatment of Atherothrombotic diseases (UDETMA), Lleida Primary health care
Atherosclerosis, Chronic Kidney Diseases, Metabolic Syndrome, PreDiabetes, Subclinical Disease and/or Syndrome
12/18
12/28
Rueda, David Arroyo
ALIGN, NCT04573478: Atrasentan in Patients With IgA Nephropathy

Active, not recruiting
3
404
Europe, Canada, Japan, US, RoW
Atrasentan, CHK-01, Atrasentan Hydrochloride, ABT-627, Placebo
Chinook Therapeutics, Inc.
IgA Nephropathy, Immunoglobulin A Nephropathy
12/26
12/26
AFFINITY, NCT04573920: Atrasentan in Patients With Proteinuric Glomerular Diseases

Active, not recruiting
2
103
Europe, US, RoW
Atrasentan, CHK-01, Atrasentan Hydrochloride, ABT-627
Novartis Pharmaceuticals
IgA Nephropathy, Focal Segmental Glomerulosclerosis, Alport Syndrome, Diabetic Kidney Disease, Diabetic Nephropathy Type 2, Immunoglobulin A Nephropathy
07/24
10/26
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
López, Marcelino Bermúdez
ILERVAS, NCT03228459: The Project: Assessing the Prevalence of Subclinical Vascular Disease and Hidden Kidney Disease

Active, not recruiting
N/A
16660
Europe
Dried blood spot test, Urine test, Artery ultrasound, Ankle-brachial index, Spirometry, Determination of advanced glycation-end products, Atrial fibrillation screening, Biological sample collection, Result and recommendation report, Pulse wave velocity
Institut de Recerca Biomèdica de Lleida, Diputació de Lleida, Jaume Arnó Renal Foundation, Unit of Detection and Treatment of Atherothrombotic diseases (UDETMA), Lleida Primary health care
Atherosclerosis, Chronic Kidney Diseases, Metabolic Syndrome, PreDiabetes, Subclinical Disease and/or Syndrome
12/18
12/28
Rueda, David Arroyo
ALIGN, NCT04573478: Atrasentan in Patients With IgA Nephropathy

Active, not recruiting
3
404
Europe, Canada, Japan, US, RoW
Atrasentan, CHK-01, Atrasentan Hydrochloride, ABT-627, Placebo
Chinook Therapeutics, Inc.
IgA Nephropathy, Immunoglobulin A Nephropathy
12/26
12/26
AFFINITY, NCT04573920: Atrasentan in Patients With Proteinuric Glomerular Diseases

Active, not recruiting
2
103
Europe, US, RoW
Atrasentan, CHK-01, Atrasentan Hydrochloride, ABT-627
Novartis Pharmaceuticals
IgA Nephropathy, Focal Segmental Glomerulosclerosis, Alport Syndrome, Diabetic Kidney Disease, Diabetic Nephropathy Type 2, Immunoglobulin A Nephropathy
07/24
10/26

Download Options